Insider Transactions in Q2 2023 at Intercept Pharmaceuticals, Inc. (ICPT)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2023
|
Andrew Saik EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
908
-1.3%
|
$9,988
$11.74 P/Share
|
|
Jun 14
2023
|
M Michelle Berrey President, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,246
-1.51%
|
$14,952
$12.04 P/Share
|
|
May 24
2023
|
Fundaro Paolo Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+15.59%
|
-
|
|
May 24
2023
|
Keith Michael Gottesdiener Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+19.81%
|
-
|
|
May 24
2023
|
Glenn Sblendorio Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+20.45%
|
-
|
|
May 24
2023
|
Luca Benatti Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+19.45%
|
-
|
|
May 24
2023
|
Srinivas Akkaraju Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+14.99%
|
-
|
|
May 24
2023
|
Daniel Bradbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+20.39%
|
-
|
|
May 24
2023
|
Nancy Miller Rich Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+21.05%
|
-
|
|
May 24
2023
|
Dagmar Rosa Bjorkeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+23.51%
|
-
|
|
May 24
2023
|
Gino Santini Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+20.35%
|
-
|
|
May 01
2023
|
Jared Freedberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
771
-1.31%
|
$13,107
$17.07 P/Share
|